EUROASPIRE (European Action on Secondary Prevention through Intervention to Reduce Events) III--a comparison of Irish and European results.

Hdl Handle:
http://hdl.handle.net/10147/253461
Title:
EUROASPIRE (European Action on Secondary Prevention through Intervention to Reduce Events) III--a comparison of Irish and European results.
Authors:
Cooney, M T; Storey, S; Taylor, L; Dudina, A; Hall, M; Hemeryck, L; Feely, J; Graham, I
Affiliation:
Department of Cardiology, AMNCH, Tallaght, Dublin.
Citation:
EUROASPIRE (European Action on Secondary Prevention through Intervention to Reduce Events) III--a comparison of Irish and European results. 2009, 102 (4):113-6 Ir Med J
Publisher:
Irish medical journal
Journal:
Irish medical journal
Issue Date:
Apr-2009
URI:
http://hdl.handle.net/10147/253461
PubMed ID:
19552291
Abstract:
The EUROASPIRE III audit was a Europe-wide study which took place in 2006/2007. The objective was to examine the control of risk factors in subjects with established cardiovascular disease. Here, we compare the Irish results to those of the other 21 European countries which participated. Control of blood cholesterol was significantly better in Irish participants, with 73% below the target of 4.5 mmol/l. Blood pressure control was less satisfactory in both Irish and European individuals, with an average of 52% of Irish participants not achieving blood pressure targets. Medication usage was high throughout, particularly anti-platelet agents, beta-blockers and, especially in Ireland, statins. Obesity figures were particularly high in Ireland and throughout Europe, with 82% Irish men and women either overweight or obese. Smoking figures in Irish women were also of concern, with 24% continuing to smoke. Cardiac rehabilitation attendance was particularly high in Ireland, with 68% attending; substantially higher than the European figure of 34%. In common with the rest of Europe, current control of body weight and blood pressure in Ireland is unsatisfactory and in need of increased consideration on the part of both patients and healthcare professionals.
Item Type:
Article
Language:
en
MeSH:
Cardiovascular Diseases; Cholesterol; Europe; Female; Humans; Hypercholesterolemia; Hypertension; Ireland; Male; Obesity; Risk Factors; Secondary Prevention
ISSN:
0332-3102

Full metadata record

DC FieldValue Language
dc.contributor.authorCooney, M Ten_GB
dc.contributor.authorStorey, Sen_GB
dc.contributor.authorTaylor, Len_GB
dc.contributor.authorDudina, Aen_GB
dc.contributor.authorHall, Men_GB
dc.contributor.authorHemeryck, Len_GB
dc.contributor.authorFeely, Jen_GB
dc.contributor.authorGraham, Ien_GB
dc.date.accessioned2012-11-27T15:31:02Z-
dc.date.available2012-11-27T15:31:02Z-
dc.date.issued2009-04-
dc.identifier.citationEUROASPIRE (European Action on Secondary Prevention through Intervention to Reduce Events) III--a comparison of Irish and European results. 2009, 102 (4):113-6 Ir Med Jen_GB
dc.identifier.issn0332-3102-
dc.identifier.pmid19552291-
dc.identifier.urihttp://hdl.handle.net/10147/253461-
dc.description.abstractThe EUROASPIRE III audit was a Europe-wide study which took place in 2006/2007. The objective was to examine the control of risk factors in subjects with established cardiovascular disease. Here, we compare the Irish results to those of the other 21 European countries which participated. Control of blood cholesterol was significantly better in Irish participants, with 73% below the target of 4.5 mmol/l. Blood pressure control was less satisfactory in both Irish and European individuals, with an average of 52% of Irish participants not achieving blood pressure targets. Medication usage was high throughout, particularly anti-platelet agents, beta-blockers and, especially in Ireland, statins. Obesity figures were particularly high in Ireland and throughout Europe, with 82% Irish men and women either overweight or obese. Smoking figures in Irish women were also of concern, with 24% continuing to smoke. Cardiac rehabilitation attendance was particularly high in Ireland, with 68% attending; substantially higher than the European figure of 34%. In common with the rest of Europe, current control of body weight and blood pressure in Ireland is unsatisfactory and in need of increased consideration on the part of both patients and healthcare professionals.en_GB
dc.language.isoenen
dc.publisherIrish medical journalen_GB
dc.rightsArchived with thanks to Irish medical journalen_GB
dc.subject.meshCardiovascular Diseases-
dc.subject.meshCholesterol-
dc.subject.meshEurope-
dc.subject.meshFemale-
dc.subject.meshHumans-
dc.subject.meshHypercholesterolemia-
dc.subject.meshHypertension-
dc.subject.meshIreland-
dc.subject.meshMale-
dc.subject.meshObesity-
dc.subject.meshRisk Factors-
dc.subject.meshSecondary Prevention-
dc.titleEUROASPIRE (European Action on Secondary Prevention through Intervention to Reduce Events) III--a comparison of Irish and European results.en_GB
dc.typeArticleen
dc.contributor.departmentDepartment of Cardiology, AMNCH, Tallaght, Dublin.en_GB
dc.identifier.journalIrish medical journalen_GB
dc.description.provinceLeinsteren

Related articles on PubMed

All Items in Lenus, The Irish Health Repository are protected by copyright, with all rights reserved, unless otherwise indicated.